1. Signaling Pathways
  2. GPCR/G Protein
  3. Neuromedin U Receptor (NMUR)
  4. NMUR1 Isoform

NMUR1

Neuromedin U receptor 1 (NMUR1) is a class A G protein-coupled receptor that mediates signaling by the neuropeptide neuromedin U (NMU) and contributes to smooth muscle contraction, immune regulation, and metabolic homeostasis[1][2]. Mechanistically, NMUR1 activation induces intracellular Ca2+ mobilization and engages Gq/G11-dependent signaling pathways, establishing NMUR1 as a key transducer of NMU-driven cellular responses[5][6]. The NMU-NMUR1 axis is also linked to inflammatory regulation and energy balance, and studies of the broader NMU system have implicated this pathway in obesity-related metabolic processes and peripheral tissue physiology[3][4]. In disease-relevant settings, NMUR1 expression has been detected in immune and peripheral tissues, supporting its use as an experimental model for investigating neuroimmune communication and metabolic regulation[1][3][7]. Compared with the related isoform NMUR2, which is predominantly expressed in the central nervous system, NMUR1 is distributed mainly in peripheral organs, particularly the gastrointestinal, immune, and urogenital systems, indicating distinct physiological functions despite recognition of the same endogenous ligand family[2][3][7]. For experimental applications, the development of selective NMUR1 agonists has enabled pharmacological separation of NMUR1- and NMUR2-mediated effects, providing valuable tools for dissecting receptor-specific biology and evaluating therapeutic mechanisms in metabolic and inflammatory research[5][6].

NMUR1 Related Products (2):

Cat. No. Product Name Effect Purity
  • HY-P10473A
    CPN-351 TFA
    Antagonist 99.60%
    CPN-351 TFA (compound 9a), a pentapeptide, is a selective antagonist of human NMUR1 with a pA2 of 7.35. The antagonistic effect of CPN-351 TFA on human NMUR1 is 10 times higher than that on NMUR2. CPN-351 TFA can be used in the study of inflammation. X
  • HY-P10473
    CPN-351
    Antagonist
    CPN-351 (compound 9a), a pentapeptide, is a selective antagonist of human NMUR1 with a pA2 of 7.35. The antagonistic effect of CPN-351 on human NMUR1 is 10 times higher than that on NMUR2. CPN-351 can be used in the study of inflammation.